Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 31, 1998

Study Completion Date

June 30, 2004

Conditions
Aging
Interventions
DRUG

Orally active growth hormone secretagogue (MK-677)

Trial Locations (1)

22908

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER

NCT00474279 - Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults | Biotech Hunter | Biotech Hunter